Apellis Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $147M | 2.5M | 59.86 |
| 2023-09-30 | $68M | 1.8M | 38.04 |
| 2023-06-30 | $644M | 7.1M | 91.10 |
| 2023-03-31 | $303M | 4.6M | 65.96 |
| 2022-12-31 | $142M | 2.7M | 51.71 |
| 2022-03-31 | $401M | 7.9M | 50.81 |
| 2021-12-31 | $251M | 5.3M | 47.28 |
| 2021-09-30 | $158M | 4.8M | 32.96 |
| 2021-06-30 | $327M | 5.2M | 63.20 |
| 2021-03-31 | $156M | 3.6M | 42.91 |
| 2020-12-31 | $174M | 3.0M | 57.20 |
| 2020-09-30 | $90M | 3.0M | 30.17 |
| 2020-06-30 | $99M | 3.0M | 32.66 |
| 2020-03-31 | $34M | 1.3M | 26.79 |
| 2019-12-31 | $24M | 792k | 30.62 |
| 2019-09-30 | $21M | 874k | 24.09 |
| 2019-06-30 | $18M | 699k | 25.34 |
| 2019-03-31 | $13M | 680k | 19.50 |
| 2018-12-31 | $9.5M | 719k | 13.19 |
| 2018-09-30 | $16M | 911k | 17.78 |
| 2018-06-30 | $21M | 962k | 22.00 |